Shang-Bo Yu

15PUBLICATIONS
35CO-AUTHORS
Characterisation of biological macromoleculesAgricultural biotechnology diagnostics (incl. biosensors)Lasers and quantum electronicsComposite and hybrid materialsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 29, 2026
Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs.

|Jan 07, 2026
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants.

Shi-Xian Gan, Yajie Zhu, Congying Guo

|Mar 26, 2025
Acyclic Cucurbit[n]uril-Enabled Detection of Aflatoxin B1 via Host-Guest Chemistry and Bioluminescent Immunoassay.

Shaowen Wu, Ke Feng, Jinlu Niu

|Jan 24, 2025
Discovery of an Ultralong-acting Nondepolarizing Neuromuscular Blocker That Displays Short Onset Time and On-Demand Rapid Reversal by a Biocompatible Antagonist.

Jingyu Yang, Yan Wu, Yue-Yang Liu

|Dec 10, 2024
Supramolecular Organic Framework that Enables Multifunctional Doxorubicin Delivery, Photofrin Post-treatment Phototoxicity Inhibition, and Heparin Neutralization.

Lingyu Zhang, Yue-Yang Liu, Yang Zong

|Sep 26, 2024
Structure-Activity Relationship Studies Leading to the Discovery of Highly Water-Soluble and Biocompatible Acyclic Cucurbit[n]uril FY-3451 as a Universal Antagonist That Rapidly Reverses Neuromuscular Blocking Agents In Vivo.

Ke Feng, Yue-Yang Liu, Yang Zong

Pageof 3

Frequent Collaborators

15 joint publications

Zhan-Ting Li

12 joint publications

Dan-Wei Zhang

10 joint publications

Wei Zhou

6 joint publications

Furong Lin